Home » Topics » BioWorld Science

BioWorld Science
RSS

Aquila's pneumococcal immunotherapeutic enters clinical trials

Nov. 15, 1996

Lilly to manufacture SangStat generic immunosuppressant

Nov. 15, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

Viral load markedly reduced by Invirase + Norvir

Nov. 15, 1996

Lead HIV protease inhibitor from ArQule

Nov. 15, 1996

Twelfth approval for Abelcet

Nov. 15, 1996

HIV protease inhibitors described by DuPont

Nov. 15, 1996

NDA filed for AmBisome

Nov. 15, 1996

ASA + ibuprofen combination effective in treating Listeria infection in mice

Nov. 15, 1996

Novel antibacterial compound from Banyu

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...